COYA
https://ir.coyatherapeutics.com/news/news-details/2024/Coya-Therapeutics-Announces-5-Million-Strategic-Investment-by-the-Alzheimers-Drug-Discovery-Foundation-ADDF/default.aspx
https://ir.coyatherapeutics.com/news/news-details/2024/Coya-Therapeutics-Provides-a-Corporate-Update-and-Reports-Unaudited-Second-Quarter-2024-Financial-Results/default.aspx
https://ir.coyatherapeutics.com/news/news-details/2024/Coya-Therapeutics-Announces-that-Results-from-a-Double-Blind-Placebo-Controlled-Study-in-Alzheimers-Disease-will-be-presented-on-October-29-2024-at-the-Clinical-Trials-on-Alzheimers-Disease-Conference-CTAD24-in-Madrid/default.aspx
https://s201.q4cdn.com/307844724/files/doc_presentations/2024/Aug/12/coya-presentation-deck-august-2024-final.pdf

GRAL
https://investors.grail.com/news-releases/news-release-details/results-grails-gallerir-multi-cancer-early-detection-blood-test
https://grail.com/press-releases/results-of-grails-galleri-multi-cancer-early-detection-blood-test-in-prostate-cancer-published-in-jco-precision-oncology/

https://investors.grail.com/news-releases/news-release-details/grail-announces-inducement-grants-under-nasdaq-listing-rule
GANX
https://www.gaintherapeutics.com/newsroom/press-releases/press-releases-2024/ainherapeuticsnnouncesositiveoplineesultsfromth20240829043502
